IMNN
Price:
$0.815
Market Cap:
$11.82M
Imunon, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company also has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. The company was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in ...[Read more]
Industry
Biotechnology
IPO Date
1999-03-01
Stock Exchange
NASDAQ
Ticker
IMNN
According to Imunon, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.77M. This represents a change of -67.07% compared to the average of 8.42M of the last 4 quarters.
The mean historical Enterprise Value of Imunon, Inc. over the last ten years is 21.14M. The current 2.77M Enterprise Value has changed 1.21% with respect to the historical average. Over the past ten years (40 quarters), IMNN's Enterprise Value was at its highest in in the June 2020 quarter at 99.87M. The Enterprise Value was at its lowest in in the September 2022 quarter at -8648647.12.
Average
21.14M
Median
16.29M
Minimum
1.94M
Maximum
41.79M
Discovering the peaks and valleys of Imunon, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 188.23%
Maximum Annual Enterprise Value = 41.79M
Minimum Annual Increase = -86.93%
Minimum Annual Enterprise Value = 1.94M
Year | Enterprise Value | Change |
---|---|---|
2023 | 1.94M | -56.15% |
2022 | 4.42M | -86.93% |
2021 | 33.79M | 188.23% |
2020 | 11.72M | -71.95% |
2019 | 41.79M | 100.40% |
2018 | 20.86M | 107.21% |
2017 | 10.06M | 30.32% |
2016 | 7.72M | -80.23% |
2015 | 39.07M | -2.48% |
2014 | 40.06M | -22.91% |
The current Enterprise Value of Imunon, Inc. (IMNN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
13.38M
5-year avg
18.73M
10-year avg
21.14M
Imunon, Inc.’s Enterprise Value is less than Exicure, Inc. (50.55M), greater than Cyclacel Pharmaceuticals, Inc. (-985182.00), greater than Histogen Inc. (-4487565.00), less than DiaMedica Therapeutics Inc. (221.15M), greater than Neoleukin Therapeutics, Inc. (-6333315.00), less than Senti Biosciences, Inc. (43.36M), greater than Hillstream BioPharma, Inc. (1.48M), less than SAB Biotherapeutics, Inc. (33.19M), greater than Quoin Pharmaceuticals, Ltd. (-667131.00), less than SAB Biotherapeutics, Inc. (33.19M), less than Cingulate Inc. (5.81M), greater than Bellicum Pharmaceuticals, Inc. (-5130674.00), less than Lisata Therapeutics, Inc. (6.65M), less than Lixte Biotechnology Holdings, Inc. (3.06M), less than Kineta, Inc. (6.78M), greater than Theriva Biologics, Inc. (-9939835.00), less than Lumos Pharma, Inc. (24.19M), less than Diffusion Pharmaceuticals Inc. (10.58M), less than Avalo Therapeutics, Inc. (10.88M), less than Catalyst Biosciences, Inc. (1.01B),
Company | Enterprise Value | Market cap |
---|---|---|
50.55M | $44.77M | |
-985182.00 | $2.00M | |
-4487565.00 | $85.44K | |
221.15M | $224.92M | |
-6333315.00 | $8.20M | |
43.36M | $19.13M | |
1.48M | $4.17M | |
33.19M | $37.84M | |
-667131.00 | $2.45M | |
33.19M | $461.46K | |
5.81M | $15.61M | |
-5130674.00 | $778.33K | |
6.65M | $25.98M | |
3.06M | $4.70M | |
6.78M | $7.05M | |
-9939835.00 | $4.73M | |
24.19M | $37.54M | |
10.58M | $8.98M | |
10.88M | $92.18M | |
1.01B | $19.42M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Imunon, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Imunon, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Imunon, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Imunon, Inc. (IMNN)?
What is the 3-year average Enterprise Value for Imunon, Inc. (IMNN)?
What is the 5-year average Enterprise Value for Imunon, Inc. (IMNN)?
How does the current Enterprise Value for Imunon, Inc. (IMNN) compare to its historical average?